Beam Therapeutics Inc (BEAM) — Cash Flow Reinvestment Rate
Beam Therapeutics Inc (BEAM) has a Cash Flow Reinvestment Rate of 0.75x as of December 2023, reinvesting $101.69 Million (capex $3.59 Million plus investments $98.10 Million) from operating cash flow of $135.07 Million. See cash generation quality of Beam Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Beam Therapeutics Inc Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Beam Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Beam Therapeutics Inc (BEAM) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Beam Therapeutics Inc (2022–2022)
Year-by-year capital reinvestment analysis for Beam Therapeutics Inc. See financial agility of Beam Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 22.65x | $510.29 Million | $22.53 Million | $48.95 Million | — |